JPRN-jRCT2080221500未知2 期
ong-term Prevention of Recurrent Gastric or Duodenal Ulcers caused by Low-dose Aspirin with Rabeprazole (E3810) Treatment. -A Multicenter, Randomized, Parallel-group, Open-label Trial-(Planetarium study)
试验速览
- 阶段
- 2 期
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Confirmed to have no recurrence of gastric or duodenal ulcer by endoscopy at the end of 24 weeks of treatment in Trial 308.
- •Need to continue receiving low-dose aspirin (81 mg/day or 100 mg/day) during this trial.
排除标准
- •Confirmed to have a recurrence of gastric or duodenal ulcer at the end of 24 weeks of treatment in Trial 308 (at the start of this trial) and thus are withdrawn from the trial.
研究者
相似试验
未知
2 期
Efficacy of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiriGastric or duodenal ulcers caused by low-dose aspirinJPRN-jRCT2080221499Eisai Co., Ltd.450
已完成
2 期
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)Gastric or Duodenal Ulcers Caused by Low-dose AspirinNCT01397448Eisai Co., Ltd.472
进行中（未招募）
1 期
Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidineEUCTR2005-004849-33-GBHS Greater Glasgow700
招募中
不适用
Prevention of gastrointestinal complications by infusion pump in patients receiving enteral nutritioInpatients receiving enteral nutrition via nasogastric tube, gastric fistula, or intestinal fistulaJPRN-UMIN000005609Division of Clinical pharmacokinetics, Faculty of Pharmacy, Keio University200
招募中
4 期
It is the study to compare non surgical treatment modality for gastroduodenal obstructioCTRI/2020/07/026501SMS Hospital and medical college